Institutional investors purchased a net $1.9 million shares of DEPO during the quarter ended September 2016 and now own 103.49% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MORGAN STANLEY & CO. LLC Bought 1.5 Million shares of Depomed Inc
SCOGGIN MANAGEMENT LP Bought 1.3 Million shares of Depomed Inc
GOVERNORS LANE LP Bought 475.3 Thousand shares of Depomed Inc